Intra-Cellular: Buoyant Caplyta Sales And Upcoming MDD Data

Intra-Cellular: Buoyant Caplyta Sales And Upcoming MDD Data Support Short-Term 'Buy'

Intra-Cellular: Buoyant Caplyta Sales And Upcoming MDD Data Support Short-Term 'Buy'

seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

New York , United States , Otsuka Pharma Rexulti , Bristol Myers Squibb , Advisory Committee , Vanda Pharmaceuticals , Pfizer , Intra Cellular Therapies , Prescription Drug User Fee Act , Negative Syndrome Scale , Psychiatry Online , Montgomery Asberg Depression Rating , Depressive Disorder , Chance To Expand Label , Depression Rating Scale , Global Impression , Severity Scale , Pocketed Rivals Could Hamper Growth , Wall Street , Seeking Alpha , Otsuka Pharma , Big Pharma , Cerevel Therapeutics , Axsome Therapeutic , Obvious Near Term Support For Lead , Buy Today On Approval Catalysts , Growing Sales , Long Term Future Looks ,